REN-REDES ENERGET. A EO 1/ PTREL0AM0008 /
2024-05-31 9:32:26 AM | Chg. -0.02 | Volume | Bid9:58:22 PM | Ask9:58:22 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.30EUR | -0.65% | 1,200 Turnover: 2,760 |
2.30Bid Size: 1,400 | 2.33Ask Size: 1,400 | 1.53 bill.EUR | 6.71% | 10.43 |
GlobeNewswire
1:00 AM
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
12:43 AM
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
GlobeNewswire
06-02
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
06-02
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
06-02
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
06-02
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
06-02
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
06-02
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
06-02
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...